The combination of SARS-CoV-2 S-E-M proteins activates TLR2 signaling increasing Nf-κB/ERK1/2 and inflammasome activation, which is attenuated by NAC, suggesting a plausible explanation of the beneficial effects of NAC observed in COVID-19 patients. This evidence concerns the gene TLR2 and COVID-19.